Amgen Stock News

Related Stocks: BK , AMGN , DUK ,

Sumitomo Mitsui Trust Holdings Inc. lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN) by 9.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,327,327 shares of the medical research companys stock after selling 236,723 shares during the period. Sumitomo Mitsui []

Orion Capital Management LLC raised its holdings in Amgen Inc. (NASDAQ:AMGN) by 42.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 500 shares of the medical research companys stock after acquiring an additional 150 shares during the period. Orion []

Examination of the market development is appeared with extraordinary exactness. This Acquired Orphan Blood Diseases Therapeutics market report incorporates a persistent market rundown like depictions that give inside and out data of various divisions. It shows the promising chances that

James Investment Research Inc. cut its position in Amgen Inc. (NASDAQ:AMGN) by 5.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,238 shares of the medical research companys stock after selling 191 shares during the quarter. James Investment Research Inc.s holdings []

Patten & Patten Inc. TN cut its stake in shares of Amgen Inc. (NASDAQ:AMGN) by 13.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,934 shares of the medical research companys stock after selling 632 shares during the period. Patten & []

BOULDER, Colo., Dec. 09, 2021 (GLOBE NEWSWIRE) -- In a new study published in Nature Genetics , scientists at deCODE genetics, a subsidiary of Amgen, used SomaLogics (NASDAQ: SLGC) SomaScan Assay to measure blood proteins in 35,559 Icelanders and mapped them to 27 million genetic sequence variants. Using this vast amount of proteomic data, these researchers hope to demonstrate that combining protein measurements at population scale with genetic data on disease will dramatically impact understanding of human diseases and potential drug targets. This new study was the largest proteomic study published to date with 170 million protein measurements.

Key Prominent Players Covered in the Adalimumab Biosimilar Market are Alfred E. Tiefenbacher, Amgen Inc., Boehringer Ingelheim International GmbH, Glenmark Pharmaceuticals Ltd, Zydus Cadila, Torrent Pharmaceuticals Ltd., Reliance Life Sciences., Emcure Pharmaceuticals Ltd, Cipla Inc., Hetero. and others Key Prominent Players Covered in the Adalimumab Biosimilar Market are Alfred E. Tiefenbacher, Amgen Inc., Boehringer Ingelheim International GmbH, Glenmark Pharmaceuticals Ltd, Zydus Cadila, Torrent Pharmaceuticals Ltd., Reliance Life Sciences., Emcure Pharmaceuticals Ltd, Cipla Inc., Hetero. and others

We cover dividend stocks often at 24/7, as they provide investors with much better income streams than U.S.

Related Stocks: AMGN , NVAX , ITCI , SRPT , BGNE , GH , ALKS , AZN , CRBU , CRL , RLYB , BHVN , ALLK , BPMC , BBIO , IOVA , DCPH , REPL ,

Related Stocks: AMGN , GH , IDXX , ALNY , NVAX , SRPT , ICLR , BHVN , CTLT , CRBU , AZN , RLYB , ABT , ASND , NBIX , DXCM , ARNA , ARGX , DCPH , BBIO , RMD , BPMC , ALLK , IOVA ,

Related Stocks: WHR , TPR , WMB , JNJ , EOG , CERN , MAS , DAL , AMGN , FIS , PVH , WRK , VTRS , CTRA ,

Tompkins Financial Corp acquired a new stake in Amgen Inc. (NASDAQ:AMGN) during the third quarter, HoldingsChannel reports. The fund acquired 25,978 shares of the medical research companys stock, valued at approximately $5,524,000. Several other hedge funds and other institutional investors have also recently made changes to their positions in AMGN. Bell Bank increased its stake []

Related Stocks: IEF , TLH , EWBC , RF , TM , CBRE , RSP , HD , CSCO , UNH , BA , AMGN ,

Amgen (AMGN) closed at $213.53 in the latest trading session, marking a +1.05% move from the prior day.